ECSP941068A - Derivados de la cefalosporina - Google Patents
Derivados de la cefalosporinaInfo
- Publication number
- ECSP941068A ECSP941068A EC1994001068A ECSP941068A ECSP941068A EC SP941068 A ECSP941068 A EC SP941068A EC 1994001068 A EC1994001068 A EC 1994001068A EC SP941068 A ECSP941068 A EC SP941068A EC SP941068 A ECSP941068 A EC SP941068A
- Authority
- EC
- Ecuador
- Prior art keywords
- lower alkyl
- hydrogen
- cycloalkyl
- alkenyl
- aniloxy
- Prior art date
Links
- HOKIDJSKDBPKTQ-UHFFFAOYSA-N 3-(acetyloxymethyl)-7-[(5-amino-5-carboxypentanoyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical class S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C(NC(=O)CCCC(N)C(O)=O)C12 HOKIDJSKDBPKTQ-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000003342 alkenyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 125000006244 carboxylic acid protecting group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- -1 lower alkyl-Qm Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
De la fórmula general: en donde R1 es un grupo acilo derivado de un ácido carboxílico; R2 es hidrógeno, hidroxilo, alquilo-Qm inferior, cicloalquilo, alcoxilo inferior, alquenilo inferior, alquenilo inferior, cicloalquenilo, alquinilo inferior, aralquilo-Qm, anilo-Qm, aniloxilo, aralcoxilo o un anillo heterocíclico, siendo el alquilo inferior, cicloalquilo, alcoxilo inferior, alquenilo inferior, cicloalquenilo, alquinilo inferior, aralquilo, anilo, aniloxilo, aralcoxilo y el anillo heterocíclico, sin substituir o substituidos con por lo menos un grupo seleccionado entre carboxilo, amino, nitro, ciano, alquilo inferior, alcoxilo inferior, hidroxilo, halógeno, -CONR4R5, -N (R5) COOR9, R5 CO-, R5 OCO- o R5 COO-, en donde R4 es hidrógeno, alquilo inferior o cicloalquilo; R5 es hidrógeno o alquilo inferior; R9 es hidrógeno, alquilo inferior, alquenilo inferior o un grupo protector de ácido carboxílico.; Q es - CO- ó - SO2; M es O ó 1 N es O, 1 ó 2 así como ésteres fácilmente hidrolizables de las mismas sales farmacéuticamente aceptables de dichos compuestos e hidratos de los compuestos de fórmula I y de sus ésteres y sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4868893A | 1993-04-16 | 1993-04-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP941068A true ECSP941068A (es) | 1994-11-16 |
Family
ID=21955891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC1994001068A ECSP941068A (es) | 1993-04-16 | 1994-04-15 | Derivados de la cefalosporina |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5523400A (es) |
| KR (1) | KR100309516B1 (es) |
| EC (1) | ECSP941068A (es) |
| RO (1) | RO114965B1 (es) |
| TN (1) | TNSN94030A1 (es) |
| UY (1) | UY23757A1 (es) |
| YU (1) | YU19494A (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996026943A1 (en) * | 1995-02-27 | 1996-09-06 | F.Hoffmann-La Roche Ag | Derivatives of 3-pyrrolidylidene-2-one-cephalosporines |
| CZ251896A3 (en) * | 1995-09-12 | 1997-04-16 | Hoffmann Ka Roche Ag F | Cephalosporin derivatives |
| US5811419A (en) * | 1996-01-16 | 1998-09-22 | Hoffmann-La Roche Inc. | Isooxacephem-derivatives |
| US5883247A (en) * | 1996-06-10 | 1999-03-16 | Hoffmann-La Roche Inc. | Preparation of cephem and isooxacephem derivatives |
| TW446707B (en) * | 1996-10-22 | 2001-07-21 | Hoffmann La Roche | Cephalosporin pyridinium derivatives |
| ES2281090T3 (es) | 1996-11-06 | 2007-09-16 | Basilea Pharmaceutica Ag | Derivados de vinilpirrolidona-cefalosporina. |
| TW415949B (en) * | 1996-12-19 | 2000-12-21 | Hoffmann La Roche | Vinyl pyrrolidine cephalosporin derivatives with basic substituents |
| US6114541A (en) * | 1997-03-10 | 2000-09-05 | Hoffmann-La Roche Inc. | Method for the preparation of α-Bromo-Lactam derivatives |
| JP4033630B2 (ja) * | 1998-06-22 | 2008-01-16 | バジリア ファルマスーチカ アーゲー | プロペニルセファロスポリン誘導体 |
| ATE370146T1 (de) | 1999-07-05 | 2007-09-15 | Basilea Pharmaceutica Ag | Verfahren zur herstellung von cephalosporin- derivaten |
| US7662955B2 (en) * | 2003-03-20 | 2010-02-16 | Orchid Chemicals And Pharmaceuticals Ltd. | Process for the preparation of cefoxitin |
| US7105659B2 (en) * | 2003-06-02 | 2006-09-12 | Aurobind - Pharma Ltd. | Process for preparing cefdinir |
| US20090214600A1 (en) * | 2008-02-25 | 2009-08-27 | Debrouse Daniel R | Methods and compositions for gastric resistant oral formulations for intestinal delivery |
| MX352760B (es) | 2011-09-09 | 2017-12-07 | Merck Sharp & Dohme Corp Star | Metodos para tratar infecciones intrapulmonares. |
| US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| DK2893929T3 (da) | 2013-03-15 | 2025-07-07 | Merck Sharp & Dohme Llc | Antibiotisk ceftolozansammensætninger |
| US20140274993A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane-tazobactam pharmaceutical compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| EP3043797B1 (en) | 2013-09-09 | 2020-04-08 | Merck Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
| CN105418641B (zh) * | 2015-12-30 | 2018-08-10 | 广东金城金素制药有限公司 | 一种原研制品质头孢曲松钠及其药物制剂 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4496562A (en) * | 1977-03-14 | 1985-01-29 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted-3-cephem-4-carboxylic acid esters |
| US4409214A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical, Co., Ltd. | 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
| US4406899A (en) * | 1982-03-04 | 1983-09-27 | Bristol-Myers Company | Cephalosporins |
| CA1213882A (en) * | 1982-03-04 | 1986-11-12 | Jun Okumura | Cephalosporins |
| IL84128A (en) * | 1986-10-13 | 1992-12-01 | Eisai Co Ltd | 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them |
| US5171854A (en) * | 1987-05-26 | 1992-12-15 | Bayer Aktiengesellschaft | Substituted vinylcephalosporins |
| GB8821797D0 (en) * | 1988-09-16 | 1988-10-19 | Beecham Group Plc | Novel compounds |
| PT620225E (pt) * | 1993-04-16 | 2003-03-31 | Basilea Pharmaceutica Ag | Derivados de cefalosporina |
-
1994
- 1994-03-21 US US08/213,562 patent/US5523400A/en not_active Expired - Lifetime
- 1994-04-13 UY UY23757A patent/UY23757A1/es not_active IP Right Cessation
- 1994-04-13 TN TNTNSN94030A patent/TNSN94030A1/fr unknown
- 1994-04-14 YU YU19494A patent/YU19494A/sh unknown
- 1994-04-15 RO RO94-00637A patent/RO114965B1/ro unknown
- 1994-04-15 KR KR1019940007920A patent/KR100309516B1/ko not_active Expired - Lifetime
- 1994-04-15 EC EC1994001068A patent/ECSP941068A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY23757A1 (es) | 1994-10-03 |
| RO114965B1 (ro) | 1999-09-30 |
| KR100309516B1 (ko) | 2006-05-25 |
| YU19494A (sh) | 1998-05-15 |
| US5523400A (en) | 1996-06-04 |
| TNSN94030A1 (fr) | 1995-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP941068A (es) | Derivados de la cefalosporina | |
| ES2185634T3 (es) | Derivados de cefalosporina. | |
| CO4970713A1 (es) | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen | |
| ES2055056T3 (es) | Derivados de pirimidopirimidina. | |
| AR011913A1 (es) | Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos. | |
| DK351788A (da) | Tetrahydroisoquinolin-2-ylderivater af carboxylsyrer som thromboxan-a2-antagonister | |
| AR012603A1 (es) | Inhibidor de proteasa, composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento; e intermediarios de sintesis | |
| ES440426A1 (es) | Un procedimiento para la preparacion de derivados de tieno- tiacina. | |
| DK448684A (da) | Alkyldiaminderivater og deres anvendelse som laegemidler | |
| ES8604601A1 (es) | Procedimiento de preparar derivados de penicilina | |
| ATE93861T1 (de) | Synthese von beta-lactamverbindungen. | |
| NO940498D0 (no) | Nye cykliske ureaforbindelser som er nyttige som antiarytmiske og antifibrillatoriske midler | |
| AR005454A1 (es) | Derivados de isooxacefem, su uso, procedimiento para su preparacion y preparaciones farmaceuticas que contienen a dichos derivados. | |
| CO4900072A1 (es) | Derivados de 1-carba-(detia)-cefalosporina | |
| ES2045514T3 (es) | Utilizacion de derivados del cromano para el tratamiento de los estados depresivos. | |
| ECSP972262A (es) | Derivados de 1-carba (detia)-cefalosporina | |
| AR006997A1 (es) | Proceso para la preparacion de derivados ureicos e intermediarios de sintesis | |
| GB9407637D0 (en) | Serotoninergic abeo-ergoline derivatives | |
| MX9706187A (es) | Derivados de 3-pirrolidiliden-2-ona-cefalosporinas. | |
| AR009122A1 (es) | Derivados de cafalosporin pridinio, procedimiento para su preparacion, preparaciones farmaceuticas que los contienen y empleo de dichos derivados | |
| ATE26275T1 (de) | Acridanon-derivate. | |
| FI944967L (fi) | Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi | |
| GT199400068A (es) | Derivados de cefalosporina | |
| ECSP972131A (es) | B - lactamas |